- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2018-000620-34.
Displaying page 1 of 1.
EudraCT Number: 2018-000620-34 | Sponsor Protocol Number: Imatinib-MS | Start Date*: 2018-04-24 | ||||||||||||||||
Sponsor Name:Department of Clinical Neuroscience, Karolinska Institutet | ||||||||||||||||||
Full Title: Imatinib for Multiple Sclerosis (MS) Relapses - a Phase II, Randomised Study | ||||||||||||||||||
Medical condition: Patients with clinically definite Multiple Sclerosis (MS) according to the McDonald Criteria, or possible MS (also named clinically isolated syndrome-CIS, as a first manifestation of MS, where ther... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Prematurely Ended) NO (Prematurely Ended) DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
